Are Escherichia coli causing recurrent cystitis just ordinary uropathogenic E. coli (UPEC) strains?

Virulence. 2025 Dec;16(1):2444689. doi: 10.1080/21505594.2024.2444689. Epub 2024 Dec 26.

Abstract

Specific determinants associated with Uropathogenic Escherichia coli (UPEC) causing recurrent cystitis are still poorly characterized. Using strains from a previous clinical study (Vitale study, clinicaltrials.gov, identifier NCT02292160) the aims of this study were (i) to describe genomic and phenotypic traits associated with recurrence using a large collection of recurrent and paired sporadic UPEC isolates and (ii) to explore within-host genomic adaptation associated with recurrence using series of 2 to 5 sequential UPEC isolates. Whole genome comparative analyses between 24 recurrent cystitis isolates (RCIs) and 24 phylogenetically paired sporadic cystitis isolates (SCIs) suggested a lower prevalence of putative mobile genetic elements (MGE) in RCIs, such as plasmids and prophages. The intra-patient evolution of the 24 RCI series over time was characterized by SNP occurrence in genes involved in metabolism or membrane transport and by plasmid loss in 5 out of the 24 RCI series. Genomic evolution occurred early in the course of recurrence, suggesting rapid adaptation to strong selection pressure in the urinary tract. However, RCIs did not exhibit specific virulence factor determinants and could not be distinguished from SCIs by their fitness, biofilm formation, or ability to invade HTB-9 bladder epithelial cells. Taken together, these results suggest a rapid but not convergent adaptation of RCIs that involves both strain- and host-specific characteristics.

Keywords: Uropathogenic Escherichia coli; genome-wide association studies; recurrent cystitis; urinary tract infections; virulence factors; whole genome sequencing.

MeSH terms

  • Biofilms / growth & development
  • Cystitis* / microbiology
  • Escherichia coli Infections* / microbiology
  • Genome, Bacterial
  • Humans
  • Phylogeny
  • Plasmids / genetics
  • Recurrence*
  • Urinary Tract Infections / microbiology
  • Uropathogenic Escherichia coli* / classification
  • Uropathogenic Escherichia coli* / genetics
  • Uropathogenic Escherichia coli* / isolation & purification
  • Uropathogenic Escherichia coli* / pathogenicity
  • Virulence / genetics
  • Virulence Factors* / genetics

Substances

  • Virulence Factors

Associated data

  • ClinicalTrials.gov/NCT02292160

Grants and funding

The VITALE study [NCT02292160] was funded by the French Ministry of Health (Programme Hospitalier de Recherche Clinique) We are grateful to Normandy Region and Rouen University for funding in part the cursus of Nicolas Vautrin.